Zimmer Biomet Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,623
4,673
5,998
7,684
7,824
7,933
Cost of Goods Sold (COGS) incl. D&A
1,372
1,390
2,016
3,035
2,732
2,842
Gross Income
3,252
3,283
3,982
4,649
5,092
5,091
SG&A Expense
1,960
1,919
2,553
3,299
3,341
3,771
EBIT
1,292
1,364
-
1,350
1,751
1,320
Unusual Expense
264
363
811
609
1,000
1,236
Non Operating Income/Expense
8
6
189
12
38
67
Interest Expense
70
63
285
356
327
292
Pretax Income
981
944
153
400
465
271
Income Tax
222
225
7
95
1,349
108
Consolidated Net Income
759
719
146
305
1,813
379
Net Income
761
720
147
306
1,814
379
Net Income After Extraordinaries
761
720
147
306
1,814
379
Net Income Available to Common
761
720
147
306
1,814
379
EPS (Basic)
4.43
4.19
0.77
1.51
8.90
1.86
Basic Shares Outstanding
170
169
187
200
202
204
EPS (Diluted)
4.43
4.19
0.77
1.51
8.90
1.86
Diluted Shares Outstanding
172
172
190
202
204
204
EBITDA
1,650
1,740
2,142
2,389
2,814
2,359
Non-Operating Interest Income
16
12
9
3
2
3
Minority Interest Expense
2
1
1
1
-
-

About Zimmer Biomet Holdings

View Profile
Address
345 East Main Street
Warsaw Indiana 46580
United States
Employees -
Website http://www.zimmerbiomet.com
Updated 07/08/2019
Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products, sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products. The company operates through three geographical segments: America, Europe and Asia Pacific. The Americas segment comprises principally of the U.